ArticleBlood advances2018
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes.
Caroline J McNamara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it